Children's Cancer Institute Australia,
Lowy Cancer Research Centre,
School of Clinical Medicine,
Faculty of Medicine & Health,
Children's Cancer Institute Australia, Lowy Cancer Research Centre,
School of Clinical Medicine, Faculty of Medicine & Health
David S. Ziegler has not added Biography.
If you are David S. Ziegler and would like to personalize this page please email our Author Liaison for assistance.
Anti-apoptosis mechanisms in malignant gliomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jan, 2008 | Pubmed ID: 18202424
Reduced incidence of second solid tumors in survivors of childhood Hodgkin's lymphoma treated without radiation therapy.
Annals of oncology : official journal of the European Society for Medical Oncology Dec, 2011 | Pubmed ID: 21393381
Outcomes in multifocal neuroblastoma as part of the neurocristopathy syndrome.
Pediatrics Aug, 2014 | Pubmed ID: 25070313
Never say never.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Feb, 2015 | Pubmed ID: 25559802
Case Report of Spontaneous Resolution of a Congenital Glioblastoma.
Pediatrics Apr, 2016 | Pubmed ID: 26980879
Too many targets, not enough patients: rethinking neuroblastoma clinical trials.
Nature reviews. Cancer Jun, 2018 | Pubmed ID: 29632319
Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma.
British journal of cancer Sep, 2018 | Pubmed ID: 30220707
International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma.
Journal of neuro-oncology Jan, 2019 | Pubmed ID: 30446898
Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma.
Journal of neuro-oncology Jan, 2019 | Pubmed ID: 30484110
Predictors of Success of Phase II Pediatric Oncology Clinical Trials.
The oncologist Aug, 2019 | Pubmed ID: 30808815
Piloting a parent and patient decision aid to support clinical trial decision making in childhood cancer.
Psycho-oncology Jul, 2019 | Pubmed ID: 31099124
Translating palbociclib to the clinic for DIPG - What is truly achievable?
EBioMedicine Jul, 2019 | Pubmed ID: 31235425
"Balancing Expectations with Actual Realities": Conversations with Clinicians and Scientists in the First Year of a High-Risk Childhood Cancer Precision Medicine Trial.
Journal of personalized medicine Feb, 2020 | Pubmed ID: 32075154
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer.
Nature medicine Nov, 2020 | Pubmed ID: 33020650
Recurrent fusions in pediatric sarcoma and brain tumors.
Cold Spring Harbor molecular case studies Dec, 2020 | Pubmed ID: 33144287
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.
Cell Dec, 2020 | Pubmed ID: 33259802
Frontiers in the treatment of glioblastoma: Past, present and emerging.
Advanced drug delivery reviews Apr, 2021 | Pubmed ID: 33486006
Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas.
Nature communications Feb, 2021 | Pubmed ID: 33579942
Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor.
NPJ precision oncology Feb, 2021 | Pubmed ID: 33580196
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG.
Cell reports Apr, 2021 | Pubmed ID: 33852836
The important role of routine cytopathology in pediatric precision oncology.
Cancer cytopathology Oct, 2021 | Pubmed ID: 34043284
Parents' experiences of postmortem tumor donation for high-grade gliomas: benefits and suggested improvements.
Neuro-oncology advances , 2021 | Pubmed ID: 34458732
Diffuse leptomeningeal glioneuronal tumour (DLGNT) in children: the emerging role of genomic analysis.
Acta neuropathologica communications Sep, 2021 | Pubmed ID: 34493325
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer.
EMBO molecular medicine Apr, 2022 | Pubmed ID: 34927798
Therapeutic Targets in Diffuse Midline Gliomas-An Emerging Landscape.
Cancers Dec, 2021 | Pubmed ID: 34944870
Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy.
Theranostics , 2022 | Pubmed ID: 35832071
Parents' understanding of genome and exome sequencing for pediatric health conditions: a systematic review.
European journal of human genetics : EJHG Nov, 2022 | Pubmed ID: 35999452
What's in a Name? Parents' and Healthcare Professionals' Preferred Terminology for Pathogenic Variants in Childhood Cancer Predisposition Genes.
Journal of personalized medicine Aug, 2022 | Pubmed ID: 36013276
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.
Neoplasia (New York, N.Y.) Jan, 2023 | Pubmed ID: 36335802
Quality of Life (QoL) of Children and Adolescents Participating in a Precision Medicine Trial for High-Risk Childhood Cancer.
Cancers Oct, 2022 | Pubmed ID: 36358729
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes.
Scientific reports Mar, 2023 | Pubmed ID: 36882456
From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer.
Advanced drug delivery reviews May, 2023 | Pubmed ID: 36931346
loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma.
Frontiers in oncology , 2023 | Pubmed ID: 36937401
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities.
Cancer cell Apr, 2023 | Pubmed ID: 37001527
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer.
Genome medicine Apr, 2023 | Pubmed ID: 37013636
LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients.
Neuro-oncology Nov, 2023 | Pubmed ID: 37075810
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience.
Frontiers in oncology , 2023 | Pubmed ID: 37124503
Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial.
European journal of cancer (Oxford, England : 1990) Apr, 2023 | Pubmed ID: 37178647
Parents' and adolescents' perspectives and understanding of information about childhood cancer precision medicine.
Cancer Nov, 2023 | Pubmed ID: 37376781
Parents' expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial.
Cancer Nov, 2023 | Pubmed ID: 37382186
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial.
Journal of personalized medicine Jun, 2023 | Pubmed ID: 37511646
Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study.
The Journal of molecular diagnostics : JMD Oct, 2023 | Pubmed ID: 37517472
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer.
Cancer research Aug, 2023 | Pubmed ID: 37523146
Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas.
Molecular cancer therapeutics Dec, 2023 | Pubmed ID: 37683275
Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives.
British journal of cancer Nov, 2023 | Pubmed ID: 37726477
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium.
Cancer discovery Feb, 2024 | Pubmed ID: 37823831
A paradigm shift in how we treat pediatric low-grade glioma-Targeting the molecular drivers.
Neuro-oncology Apr, 2024 | Pubmed ID: 38243845
Communicating with families of young people with hard-to-treat cancers: Healthcare professionals' perspectives on challenges, skills, and training.
Palliative & supportive care Jun, 2024 | Pubmed ID: 38263685
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.
The Journal of clinical investigation Feb, 2024 | Pubmed ID: 38319732
A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor.
Targeted oncology May, 2024 | Pubmed ID: 38546944
Preclinical evaluation of protein synthesis inhibitor omacetaxine in pediatric brainstem gliomas.
Neuro-oncology advances , 2024 | Pubmed ID: 38550394
Co-design of a paediatric oncology medicines database (ProCure) to support complex care provision for children with a hard-to-treat cancer.
Frontiers in medicine , 2024 | Pubmed ID: 38606155
Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors.
Methods in molecular biology (Clifton, N.J.) , 2024 | Pubmed ID: 38676797
Precision-guided treatment in high-risk pediatric cancers.
Nature medicine Jul, 2024 | Pubmed ID: 38844796
Liver disease and transplantation in telomere biology disorders: An international multicenter cohort.
Hepatology communications Jul, 2024 | Pubmed ID: 38896081
The feasibility and acceptability of collecting psychosocial outcome measures embedded within a precision medicine trial for childhood cancer.
Cancer medicine Jun, 2024 | Pubmed ID: 38898768
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec, 2024 | Pubmed ID: 39110925
Barriers to access of precision guided therapies for children with high-risk cancer.
Pediatric blood & cancer Nov, 2024 | Pubmed ID: 39185694
When genetics and pediatric cancer collide: Understanding and optimizing families' experiences.
Neuro-oncology advances , 2024 | Pubmed ID: 39220248
Novel paediatric case of a spinal high-grade astrocytoma with piloid features in a patient with Noonan Syndrome.
NPJ precision oncology Oct, 2024 | Pubmed ID: 39427038
Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodes.
The Lancet regional health. Western Pacific Dec, 2024 | Pubmed ID: 39553416
Second Opinion Seeking in Paediatric Oncology: Motivations and Predictors.
Psycho-oncology Nov, 2024 | Pubmed ID: 39558466
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.
Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2025 | Pubmed ID: 39625867
Germline analysis of an international cohort of pediatric diffuse midline glioma patients.
Neuro-oncology Mar, 2025 | Pubmed ID: 40072012
The Super Enhancer-Driven Long Noncoding RNA PRKCQ-AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule Compounds.
Advanced science (Weinheim, Baden-Wurttemberg, Germany) Mar, 2025 | Pubmed ID: 40103284
Whatever It Takes: Parents' Perspectives of Patient-Derived Xenograft Mouse Models for Poor Prognosis Childhood Cancer.
JCO precision oncology Apr, 2025 | Pubmed ID: 40209140